An Interprofessional Team for Disease-Modifying Therapy in Alzheimer Disease Implementation | Neurology Clinical Practice
BackgroundLecanemab and other new amyloid-targeting immunotherapies for Alzheimer disease show notable promise but may also pose significant risk for patients.Recent FindingsTo facilitate the implementation and monitoring of lecanemab infusions at our …